Reuters logo
BRIEF-Enzymatica announces the results from the clinical study ENZY-002
December 21, 2016 / 8:09 AM / 9 months ago

BRIEF-Enzymatica announces the results from the clinical study ENZY-002

Dec 21 (Reuters) - Enzymatica AB (publ) :

* Says ENZY-002 did not meet its primary endpoint of significantly lowering virus load compared to placebo in this mild experimental model of common cold

* Primary endpoint and secondary endpoint did not show significant difference between coldzyme and placebo

* Remains committed to pursue its plan of international expansion of coldzyme Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below